Mingdom Alpha
Alpha Rank
10 shown of 10 matches · as of 2026-09-30
Filters
| #Displayed row position. | Ticker | CoreCore: pure Alpha model score. Click to sort Core first; the default table order is RS first. | RSRS Rank: pure stock-vs-market relative strength percentile. Click to sort. | Vol vs avgLatest daily share volume divided by average share volume over the prior 20 sessions. Context only; not a directional signal. | Avg $ volAverage daily close multiplied by shares traded over the latest 20 sessions. A liquidity and capacity context. | AvgAvg: simple average of the Core and RS scores. Display/sort lens only; it does not change Alpha Rank. | BusinessClick sector or industry to filter peers. Click again to clear that facet. |
|---|---|---|---|---|---|---|---|
| 1•Unchanged | MRNAModerna, Inc.Sector: HealthcareIndustry: BiotechnologyOpen MRNA on Seeking Alpha in a new tab.52-Week Range Position: 91%. Current price location relative to the 52-week low (0%) and 52-week high (100%).Moderna, Inc.HealthcareBiotechnologyCore 0.2RS 99.0Avg 49.6Vol/avg 1.3x · Avg $2.4B | 0.2 | 99.0 | 1.3x | $2.4B | 49.6 | Moderna, Inc.HealthcareBiotechnology |
| 2•Unchanged | TWSTTwist Bioscience CorporationSector: HealthcareIndustry: BiotechnologyOpen TWST on Seeking Alpha in a new tab.52-Week Range Position: 98%. Current price location relative to the 52-week low (0%) and 52-week high (100%).Twist Bioscience CorporationHealthcareBiotechnologyCore 22.0RS 98.8Avg 60.4Vol/avg 1.3x · Avg $340.0M | 22.0 | 98.8 | 1.3x | $340.0M | 60.4 | Twist Bioscience CorporationHealthcareBiotechnology |
| 3↑+14 (prior: #105) | TECHBio-Techne CorporationSector: HealthcareIndustry: BiotechnologyOpen TECH on Seeking Alpha in a new tab.52-Week Range Position: 99%. Current price location relative to the 52-week low (0%) and 52-week high (100%).Bio-Techne CorporationHealthcareBiotechnologyCore 22.4RS 84.5Avg 53.4Vol/avg 0.9x · Avg $222.1M | 22.4 | 84.5 | 0.9x | $222.1M | 53.4 | Bio-Techne CorporationHealthcareBiotechnology |
| 4↓-15 (prior: #98) | INCYIncyte CorporationSector: HealthcareIndustry: BiotechnologyOpen INCY on Seeking Alpha in a new tab.52-Week Range Position: 77%. Current price location relative to the 52-week low (0%) and 52-week high (100%).Incyte CorporationHealthcareBiotechnologyCore 41.5RS 80.9Avg 61.2Vol/avg 1.1x · Avg $193.4M | 41.5 | 80.9 | 1.1x | $193.4M | 61.2 | Incyte CorporationHealthcareBiotechnology |
| 5↑+9 (prior: #183) | VRTXVertex Pharmaceuticals IncorporatedSector: HealthcareIndustry: BiotechnologyOpen VRTX on Seeking Alpha in a new tab.52-Week Range Position: 79%. Current price location relative to the 52-week low (0%) and 52-week high (100%).Vertex Pharmaceuticals IncorporatedHealthcareBiotechnologyCore 11.1RS 71.0Avg 41.1Vol/avg 1.1x · Avg $535.5M | 11.1 | 71.0 | 1.1x | $535.5M | 41.1 | Vertex Pharmaceuticals IncorporatedHealthcareBiotechnology |
| 6↑+22 (prior: #202) | REGNRegeneron Pharmaceuticals, Inc.Sector: HealthcareIndustry: BiotechnologyOpen REGN on Seeking Alpha in a new tab.52-Week Range Position: 69%. Current price location relative to the 52-week low (0%) and 52-week high (100%).Regeneron Pharmaceuticals, Inc.HealthcareBiotechnologyCore 32.9RS 70.0Avg 51.5Vol/avg 1.2x · Avg $570.3M | 32.9 | 70.0 | 1.2x | $570.3M | 51.5 | Regeneron Pharmaceuticals, Inc.HealthcareBiotechnology |
| 7↓-44 (prior: #157) | CRSPCRISPR Therapeutics AGSector: HealthcareIndustry: BiotechnologyOpen CRSP on Seeking Alpha in a new tab.52-Week Range Position: 33%. Current price location relative to the 52-week low (0%) and 52-week high (100%).CRISPR Therapeutics AGHealthcareBiotechnologyCore 1.2RS 66.7Avg 33.9Vol/avg 0.8x · Avg $83.9M | 1.2 | 66.7 | 0.8x | $83.9M | 33.9 | CRISPR Therapeutics AGHealthcareBiotechnology |
| 8↑+27 (prior: #391) | MDGLMadrigal Pharmaceuticals, Inc.Sector: HealthcareIndustry: BiotechnologyOpen MDGL on Seeking Alpha in a new tab.52-Week Range Position: 50%. Current price location relative to the 52-week low (0%) and 52-week high (100%).Madrigal Pharmaceuticals, Inc.HealthcareBiotechnologyCore 49.1RS 40.3Avg 44.7Vol/avg 1.2x · Avg $120.2M | 49.1 | 40.3 | 1.2x | $120.2M | 44.7 | Madrigal Pharmaceuticals, Inc.HealthcareBiotechnology |
| 9↓-44 (prior: #387) | ARWRArrowhead Pharmaceuticals, Inc.Sector: HealthcareIndustry: BiotechnologyOpen ARWR on Seeking Alpha in a new tab.52-Week Range Position: 52%. Current price location relative to the 52-week low (0%) and 52-week high (100%).Arrowhead Pharmaceuticals, Inc.HealthcareBiotechnologyCore 0.3RS 29.5Avg 14.9Vol/avg 0.8x · Avg $156.3M | 0.3 | 29.5 | 0.8x | $156.3M | 14.9 | Arrowhead Pharmaceuticals, Inc.HealthcareBiotechnology |
| 10↓-14 (prior: #474) | BBIOBridgeBio Pharma, Inc.Sector: HealthcareIndustry: BiotechnologyOpen BBIO on Seeking Alpha in a new tab.52-Week Range Position: 35%. Current price location relative to the 52-week low (0%) and 52-week high (100%).BridgeBio Pharma, Inc.HealthcareBiotechnologyCore 32.3RS 20.2Avg 26.3Vol/avg 1.1x · Avg $185.2M | 32.3 | 20.2 | 1.1x | $185.2M | 26.3 | BridgeBio Pharma, Inc.HealthcareBiotechnology |